{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:07:14Z","timestamp":1789679234163,"version":"4.0.1"},"reference-count":32,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,5,31]]},"DOI":"10.1536\/ihj.24-697","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T22:08:01Z","timestamp":1747260481000},"page":"463-474","source":"Crossref","is-referenced-by-count":9,"title":["Tetrandrine Improves Ventricular Remodeling and Inflammation via Inhibition of the MAPK\/NF-\u03baB Pathway"],"prefix":"10.1536","volume":"66","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoying","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhang","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yerra VG, Batchu SN, Kaur H, <i>et al<\/i>. Pressure overload induces ISG15 to facilitate adverse ventricular remodeling and promote heart failure. J Clin Invest 2023; 133: e161453.","DOI":"10.1172\/JCI161453"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mishra S, Kass DA. Cellular and molecular pathobiology of heart failure with preserved ejection fraction. Erratum in: Nat Rev Cardiol 2021; 18: 400-23.","DOI":"10.1038\/s41569-020-00480-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Yang N, Zou C, Luo W, <i>et al<\/i>. Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signaling. Erratum in: Phytother Res 2023; 37: 578-91.","DOI":"10.1002\/ptr.7635"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wang M, Han X, Yu T, <i>et al<\/i>. OTUD1 promotes pathological cardiac remodeling and heart failure by targeting STAT3 in cardiomyocytes. Theranostics 2023; 13: 2263-80.","DOI":"10.7150\/thno.83340"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ye B, Zhou H, Chen Y, <i>et al<\/i>. USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes. Circ Res 2023; 132: 465-80.","DOI":"10.1161\/CIRCRESAHA.122.321849"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dai C, Luo W, Chen Y, <i>et al<\/i>. Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation. Phytomedicine 2022; 103: 154238.","DOI":"10.1016\/j.phymed.2022.154238"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Arf\u00e8 A, Scotti L, Varas-Lorenzo C, <i>et al<\/i>. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study. BMJ 2016; 354: i4857.","DOI":"10.1136\/bmj.i4857"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Dick SA, Epelman S. Chronic Heart Failure and Inflammation: What Do We Really Know? Circ Res 2016; 119: 159-76.","DOI":"10.1161\/CIRCRESAHA.116.308030"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Swirski FK, Nahrendorf M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nat Rev Immunol 2018; 18: 733-44.","DOI":"10.1038\/s41577-018-0065-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ye S, Huang H, Han X, <i>et al<\/i>. Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling. Circ Res 2023; 132: 707-22.","DOI":"10.1161\/CIRCRESAHA.122.322259"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Bhagya N, Chandrashekar KR. Tetrandrine--A molecule of wide bioactivity. Phytochemistry 2016; 125: 5-13.","DOI":"10.1016\/j.phytochem.2016.02.005"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lu Q, Jiang H, Zhu Q, <i>et al<\/i>. Tetrandrine Ameliorates Rheumatoid Arthritis in Mice by Alleviating Neutrophil Activities. Evid Based Complement Alternat Med 2022; 2022: 8589121.","DOI":"10.1155\/2022\/8589121"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Semwal DK, Badoni R, Semwal R, Kothiyal SK, Singh GJ, Rawat U. The genus Stephania (Menispermaceae): chemical and pharmacological perspectives. J Ethnopharmacol 2010; 132: 369-83.","DOI":"10.1016\/j.jep.2010.08.047"},{"key":"14","unstructured":"14. Jiang HX. [Preliminary study of the mechanism of silicosis therapy by tetrandrine]. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi 1983; 6: 92-4."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jiang L, Zhou X, Zhao X, <i>et al<\/i>. Tetrandrine downregulates TRPV2 expression to ameliorate myocardial ischemia\/reperfusion injury in rats via regulation of cardiomyocyte apoptosis, calcium homeostasis and mitochondrial function. Eur J Pharmacol 2024; 964: 176246.","DOI":"10.1016\/j.ejphar.2023.176246"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Zhang TJ, Guo RX, Li X, Wang YW, Li YJ. Tetrandrine cardioprotection in ischemia-reperfusion (I\/R) injury via JAK3\/STAT3\/Hexokinase II. Eur J Pharmacol 2017; 813: 153-60.","DOI":"10.1016\/j.ejphar.2017.08.019"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shen DF, Tang QZ, Yan L, <i>et al<\/i>. Tetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1\/2 signalling. Br J Pharmacol 2010; 159: 970-81.","DOI":"10.1111\/j.1476-5381.2009.00605.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Guo RM, Xu WM, Lin JC, <i>et al<\/i>. Activation of the p38 MAPK\/NF-\u03baB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells. Mol Med Rep 2013; 8: 603-8.","DOI":"10.3892\/mmr.2013.1554"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Li W, Huang Z, Luo Y, <i>et al<\/i>. Tetrandrine alleviates atherosclerosis via inhibition of STING-TBK1 pathway and inflammation in macrophages. Int Immunopharmacol 2023; 119: 110139.","DOI":"10.1016\/j.intimp.2023.110139"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cheng YW, Zhang ZB, Lan BD, <i>et al<\/i>. PDGF-D activation by macrophage-derived uPA promotes AngII-induced cardiac remodeling in obese mice. J Exp Med 2021; 218: e20210252.","DOI":"10.1084\/jem.20210252"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Xu W, Chen S, Wang X, <i>et al<\/i>. Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases. Pharmacol Ther 2021; 217: 107659.","DOI":"10.1016\/j.pharmthera.2020.107659"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chu Y, Zhu Y, Zhang Y, <i>et al<\/i>. Tetrandrine attenuates intestinal epithelial barrier defects caused by colitis through promoting the expression of Occludin via the AhR-miR-429 pathway. FASEB J 2021; 35: e21502.","DOI":"10.1096\/fj.202002086RR"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Huang YL, Cui SY, Cui XY, <i>et al<\/i>. Tetrandrine, an alkaloid from S. tetrandra exhibits anti-hypertensive and sleep-enhancing effects in SHR via different mechanisms. Phytomedicine 2016; 23: 1821-9.","DOI":"10.1016\/j.phymed.2016.10.021"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wang X, Yang Y, Yang D, <i>et al<\/i>. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1. J Vasc Surg 2016; 64: 1468-77.","DOI":"10.1016\/j.jvs.2015.09.016"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Xu L, Brink M. mTOR, cardiomyocytes and inflammation in cardiac hypertrophy. Biochim Biophys Acta 2016; 1863: 1894-903.","DOI":"10.1016\/j.bbamcr.2016.01.003"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Wang L, Zhang YL, Lin QY, <i>et al<\/i>. CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration. Eur Heart J 2018; 39: 1818-31.","DOI":"10.1093\/eurheartj\/ehy085"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Wang M, Luo W, Yu T, <i>et al<\/i>. Diacerein alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the MAPKs\/c-Myc pathway. Phytomedicine 2022; 106: 154387.","DOI":"10.1016\/j.phymed.2022.154387"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Chen H, Wang X, Yan X, Cheng X, He X, Zheng W. RETRACTED: LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK\/NFkappaB. Int Immunopharmacol 2018; 55: 69-76.","DOI":"10.1016\/j.intimp.2017.11.038"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Liu F, Fan LM, Geng L, Li JM. p47(phox)-Dependent Oxidant Signalling through ASK1, MKK3\/6 and MAPKs in Angiotensin II-Induced Cardiac Hypertrophy and Apoptosis. Antioxidants (Basel) 2021; 10: 1363.","DOI":"10.3390\/antiox10091363"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Li X, Jin Q, Wu YL, <i>et al<\/i>. Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-kappaB signaling. Int Immunopharmacol 2016; 36: 263-70.","DOI":"10.1016\/j.intimp.2016.04.039"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ma ZG, Yuan YP, Fan D, <i>et al<\/i>. IRX2 regulates angiotensin II-induced cardiac fibrosis by transcriptionally activating EGR1 in male mice. Nat Commun 2023; 14: 4967.","DOI":"10.1038\/s41467-023-40639-6"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Lv SL, Zeng ZF, Gan WQ, <i>et al<\/i>. Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation. Acta Pharmacol Sin 2021; 42: 2016-32.","DOI":"10.1038\/s41401-021-00703-7"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/3\/66_24-697\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:04:31Z","timestamp":1748664271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/3\/66_24-697\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,31]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.24-697","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,31]]},"article-number":"24-697"}}